Select Page
Recommendations for unleashing meaningful innovation through regulatory reform

Recommendations for unleashing meaningful innovation through regulatory reform

by | Nov 10, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

What do we know when a new medicine is approved? What are the regulatory requirements for new medicines? What happens once a new drug is on the market? Following the first  of the EPHA #A2MDialogues,  our panelists Andrea Cipriani, Lydia Meheus, Huseyin Naci and Beate...
Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

by | Sep 18, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments

The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...
Public health must be the leading priority of Europe’s pharmaceutical sector

Public health must be the leading priority of Europe’s pharmaceutical sector

by | Jul 13, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...
What lies ahead for health under the German Presidency?

What lies ahead for health under the German Presidency?

by | Jul 9, 2020 | #EU4Health, Clean Air | Latest Developments, COVID-19, Digital Health | Latest Developments, Europe and Health, Health Inequalities, Universal Access and Affordable Medicines | Latest Developments

Germany assumed the Presidency of the Council of the European Union from 1 July, but in quite different circumstances from what was originally foreseen, with the response to tackling COVID-19, and its health, economic and social consequences being the defining issue...

Follow us

Contact

COVID-19 UPDATE

PLEASE NOTE THAT THE EPHA OFFICES UNTIL FURTHER NOTICE. PHONE LINES WILL NOT BE ACTIVE. PLEASE CONTACT MEMBERS OF THE STAFF BY EMAIL.

epha@epha.org
+32 (0) 2 230 30 56

Rue de Trèves 49-51,
1040 Brussels (BELGIUM)

Transparency Register Number:
18941013532-08

PRESS INQUIRIES:
rosemary@epha.org
+32 (0) 474 32 19 18

Get the EPHA Newsletter

Become an EPHA Member

euroflagThe European Public Health Alliance has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.